nach oben

Erschienen in:

2022 | OriginalPaper | Buchkapitel

2. Praktische Schmerztherapie

verfasst von : Boris Zernikow, Michael Printz

Erschienen in: Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Nahezu alle Kinder mit lebenslimitierenden Erkrankungen leiden am Lebensende unter Schmerzen. Im klinischen Alltag kommt es oft zu einer eklatanten Fehlversorgung in Form von Unter- oder Überversorgung. In diesem Kapitel werden praktisch umsetzbare Schmerztherapieempfehlungen auf dem Boden wissenschaftlicher Erkenntnisse gegeben. Grundlegendes Wissen über Schmerz im Kontext der Erkrankung, Schmerzempfinden und Schmerzbotschaften sowie Methoden zur Schmerzmessung, auch bei nicht mitteilungsfähigen Kindern, werden ebenso vermittelt wie Fakten zur medikamentösen und nicht medikamentösen Schmerztherapie. Ein besonderer Fokus liegt dabei auf dem WHO Stufenschema sowie der Vorstellung der wichtigsten Analgetika (Nicht-Opioide sowie Opiode) und Adjuvanzien. Ein Unterkapitel über das korrekte Ausstellen von BtM-Rezepten nimmt auch die organisatorisch-rechtlichen Aspekte in den Blick.

Bezugsquelle: 7 www.nofamed.de; MAD 300 Nasenzerstäuber der Firma LMA oder Pumpsprays zur Befüllung in der Apotheke (weitere Informationen unter 7 www.intranasal.net).

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn; Tel. +49-(0)228-99 307–4321; Fax: +49-(0)228 99 307-5207; 7 www.bfarm.de.

Ahmedzai SH, Nauck F, Bar-Sela G et al (2012) A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliat Med 26(1):50–60PubMedPubMedCentralCrossRef

Alhashemi JA, Daghistani MF (2006) Effects of intraoperative i.v. acetaminophen vs i.m. meperidine on post-tonsillectomy pain in children. Br J Anaesth 96:790–795PubMedCrossRef

Allegaert K, Anderson BJ, Verbesselt R et al (2005) Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity. Br J Anaesth 95:231–239PubMedCrossRef

Allington N, Vivegnis D, Gerard P (2005) Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. Acta Paediatr Belg 71:91–97

American Academy of Pediatrics Committee on D (1992) Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 89:1110–1115CrossRef

Anderson BJ (2008) Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth 18:915–921PubMedCrossRef

Anghelescu DL, Tesney JM (2019) Neuropathic pain in pediatric oncology: a clinical decision algorithm. Pediatr Drugs 21(2):59–70CrossRef

Anghelescu DL, Oakes LL, Hankins GM (2010) Treatment of pain in children after limb-sparing surgery: an institution’s 26-year experience. Pain Manag Nurs 12(2):82–94PubMedPubMedCentralCrossRef

Anghelescu DL, Faughnan LG, Hankins GM et al (2011) Methadone use in children and young adults at a cancer center: a retrospective study. J Opioid Manag 7(5):353–361PubMedPubMedCentralCrossRef

Arai L, Stayer S, Schwartz R et al (1996) The use of ondansetron to treat pruritus associated with intrathecal morphine in two paediatric patients. Paediatr Anaesth 6(4):337–339PubMedCrossRef

Ashburn MA, Slevin KA, Messina J et al (2011) The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain. Anesth Analg 112(3):693–702PubMedCrossRef

Ayonrinde OT, Bridge DT (2000) The rediscovery of methadone for cancer pain management. Med J Aust 173(10):536–540PubMedCrossRef

Babul N (1992) Putative role of hydromorphone metabolites in myoclonus. Pain 51(2):260–261. Erratum in: Pain 1993, 52:123PubMedCrossRef

Balyan R, Mecoli M, Venkatasubramanian R et al (2017) CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients. Pharmacogenomics 18(4):337–348PubMedPubMedCentralCrossRef

Bandschapp O, Filitz J, Urwyler A et al (2011) Tropisetron blocks analgesic action of acetaminophen: a human pain model study. Pain 152:1304–1310PubMedCrossRef

Bee LA, Bannister K, Rahman W et al (2011) Mu-opioid and noradrenergic [alpha] 2-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats. Pain 152(31):39

Beerepoot S, Nierkens S, Boelens JJ et al (2019) Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective. Orphanet J Rare Dis 14(1):1–13CrossRef

Beringer RM, Thompson JP, Parry S et al (2011) Intravenous paracetamol overdose: two case reports and a change to national treatment guidelines. Arch Dis Child 96(3):307–308PubMedCrossRef

Biersdorff KK (1991) Pain insensitivity and indifference: alternative explanations for some medical catastrophes. Ment Retard 29(6):359–362PubMed

Biersdorff KK (1994) Incidence of significantly altered pain experience among individuals with developmental disabilities. Am J Ment Retard 98(5):619–631PubMed

Blankenburg M, Boekens H, Hechler T et al (2010) Reference values for quantitative sensory testing in children and adolescents: developmental and gender differences of somatosensory perception. Pain 149(1):76–88PubMedCrossRef

Blankenburg M, Meyer D, Hirschfeld G et al (2011) Developmental and sex differences in somatosensory perception-a systematic comparison of 7- versus 14-year-olds using quantitative sensory testing. Pain 152(11):2625–2631PubMedCrossRef

Blankenburg M, Tietze AL, Hechler T et al (2013) SNAKE: the development and validation of a questionnaire on sleep disturbances in children with severe psychomotor impairment. Sleep Med 14(4):339–51

Blankenburg M, Junker J, Hirschfeld G et al (2018) Quantitative sensory testing profiles in children, adolescents and young adults (6–20 years) with cerebral palsy: hints for a neuropathic genesis of pain syndromes. Eur J Paediatr Neurol 22(3):470–481PubMedCrossRef

Borland M, Jacobs I, King B et al (2007) A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med 49(3):335–340PubMedCrossRef

Breau LM, Burkitt C (2009) Assessing pain in children with intellectual disabilities. Pain Res Manag 14(2):116–120PubMedPubMedCentralCrossRef

Breau LM, Finley GA, McGrath PJ et al (2002) Validation of the non-communicating children’s pain checklist- postoperative version. Anesthesiology 96(3):528–535PubMedCrossRef

Breitfeld C, Peters J, Vockel T et al (2003) Emetic effects of morphine and piritramide. Br J Anaesth 91(2):218–223PubMedCrossRef

Bruera E, Palmer JL, Rico MA et al (2004) Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol 22(1):185–192PubMedCrossRef

Butkovic D, Toljan S, Mihovilovic-Novak B (2006) Experience with gabapentin for neuropathic pain in adolescents: report of five cases. Paediatr Anaesth 16(3):325–329PubMedCrossRef

Candy B, Jones L, Larkin PJ et al (2015) Laxatives for the management of constipation in people receiving palliative care. Cochrane Database Syst Rev (5):CD003448

Cepeda MS, Africano JM, Manrique AM et al (2002) The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period. Pain 96(1–2):73–79PubMedCrossRef

Cepeda MS, Alvarez H, Morales H et al (2004) Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects. Pain 107(1–2):41–46PubMedCrossRef

Cheung CL, van Dijk M, Green JW et al (2007) Effects of low-dose naloxone on opioid therapy in pediatric patients: a retrospective case-control study. Intensive Care Med 33(1):190–194PubMedCrossRef

Chicoine MR, Park TS, Kaufman BA (1997) Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy. J Neurosurg 86(1):34–39PubMedCrossRef

Cole J, Shepherd M, Young P (2009) Intranasal fentanyl in 1–3-year-olds: a prospective study of the effectiveness of intranasal fentanyl as acute analgesia. Emerg Med Australas 21(5):395–400PubMed

Collins JJ, Berde CB, Grier HE et al (1995a) Massive opioid resistance in an infant with a localized metastasis to the midbrain periaqueductal gray. Pain 63(2):271–275PubMedCrossRef

Collins JJ, Grier HE, Kinney HC et al (1995b) Control of severe pain in children with terminal malignancy. J Pediatr 126(4):653–657PubMedCrossRef

Collins JJ, Grier HE, Sethna NF et al (1996) Regional anesthesia for pain associated with terminal pediatric malignancy. Pain 65(1):63–69PubMedCrossRef

Conway M, White N, Jean CS et al (2009) Use of continuous intravenous ketamine for end-stage cancer pain in children. J Pediatr Oncol Nurs 26(2):100–106PubMedCrossRef

Coombes L, Burke K, Anderson A-K (2017) The use of rapid onset fentanyl in children and young people for breakthrough cancer pain. Scand J Pain 17(1):256–259PubMedCrossRef

Coté CJ, Wilson S, Pediatrics AAO et al (2019) Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures. Pediatrics 143(6):e20191000PubMedCrossRef

Courade M, Bertrand A, Guerrini-Rousseau L et al (2019) Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study. BMJ Support Palliat Care. [published Online First: 31 May 2019]

Cuer JC, Dapoigny M, Larpent JL et al (1989) Effects of buprenorphine on motor activity of the sphincter of Oddi in man. Eur J Clin Pharmacol 36(2):203–204PubMedCrossRef

Davies D, DeVlaming D, Haines C (2008) Methadone analgesia for children with advanced cancer. Pediatr Blood Cancer 51(3):393–397PubMedCrossRef

Doyle E, Morton NS, McNicol LR (1994) Comparison of patient-controlled analgesia in children by iv and sc routes of administration. Br J Anaesth 72(5):533–536PubMedCrossRef

Drake R, Frost J, Collins JJ (2003) The symptoms of dying children. J Pain Symptom Manag 26(1):594–603CrossRef

Drake R, Longworth J, Collins JJ (2004) Opioid rotation in children with cancer. J Palliat Med 7:419–422PubMedCrossRef

Dreier LA, Wager J, Blankenburg M et al (2018a) The Unfavorable Alliance of Pain and Poor Sleep in Children with Life-Limiting Conditions and Severe Psychomotor Impairment. Children (Basel, Switzerland) 5(7):E82

Dreier LA, Zernikow B, Blankenburg M et al (2018b) A Sleep Questionnaire for Children with Severe Psychomotor Impairment (SNAKE)—Concordance with a Global Rating of Sleep Quality. Children 5(2):20

Duarte NT, de Oliveira RB, Martins IG et al (2020) Can children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review. Int J Oral Maxillofac Surg. 49(2):183–91

Dübbers A, Boos J (1997) Fakten zur Sedierung von Kindern. Zuckerschwerdt, München

Eccleston C, Fisher E, Cooper TE et al (2019) Pharmacological interventions for chronic pain in children: an overview of systematic reviews. Pain 160(8):1698–1707PubMedCrossRef

Eerdekens M, Beuter C, Lefeber C et al (2019) The challenge of developing pain medications for children: therapeutic needs and future perspectives. J Pain Res 12:1649–1664PubMedPubMedCentralCrossRef

Egunsola O, Wylie CE, Chitty KM et al (2019) Systematic review of the efficacy and safety of gabapentin and pregabalin for pain in children and adolescents. Anesth Analg 128(4):811–819PubMedCrossRef

Erhan E, Inal MT, Aydinok Y et al (2007) Tramadol infusion for the pain management in sickle cell disease: a case report. Paediatr Anaesth 17:84–86PubMedCrossRef

Finkel JC, Finley A, Greco C et al (2005) Transdermal fentanyl in the management of children with chronic severe pain: results from an international study. Cancer 104(12):2847–2857PubMedCrossRef

Finkel JC, Goldberg J, Rosenburg R et al (2019) First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18. J Pain Res 12:1925–1936PubMedPubMedCentralCrossRef

Flerlage JE, Baker JN (2015) Methylnaltrexone for opioid-induced constipation in children and adolescents and young adults with progressive incurable cancer at the end of life. J Palliat Med 18(7):631–633PubMedPubMedCentralCrossRef

Frey TM, Florin TA, Caruso M et al (2019) Effect of intranasal ketamine vs fentanyl on pain reduction for extremity injuries in children: the PRIME randomized clinical trial. JAMA Pediatr 173(2):140–146PubMedCrossRef

Friedrichsdorf S, Zernikow B (2004) Fentanyl bei der Schmerztherapie von Kindern jenseits des Neugeborenenalters. Kinder- Jugendmed 4(5):168–176CrossRef

Friedrichsdorf SJ, Nugent AP, Strobl AQ (2013) Codeine-associated pediatric deaths despite using recommended dosing guidelines: three case reports. J Opioid Manag 9(2):151–155PubMedCrossRef

Garten L, Bührer C (2012) Reversal of morphine-induced urinary retention after methylnaltrexone. Arch Dis Child Fetal Neonatal Ed 97(2):F151–F1F3PubMedCrossRef

Garten L, Degenhardt P, Bührer C (2011) Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone. J Pediatr Surg 46(3):e13–ee5PubMedCrossRef

Gobbo M, Verzegnassi F, Ronfani L et al (2018) Multicenter randomized, double-blind controlled trial to evaluate the efficacy of laser therapy for the treatment of severe oral mucositis induced by chemotherapy in children: laMPO RCT. Pediatr Blood Cancer 65(8):e27098PubMedCrossRef

Goddard JM, Reaney RL (2018) Lidocaine 5 % – medicated plaster (Versatis) for localised neuropathic pain: results of a multicentre evaluation of use in children and adolescents. Br J Pain 12(3):189–193

Granry JC, Rod B, Monrigal JP et al (1997) The analgesic efficacy of an injectable prodrug of acetaminophen in children after orthopaedic surgery. Paediatr Anaesth 7(6):445–449PubMedCrossRef

Grover AS, Mitchell PD, Manzi SF et al (2018) Initial pain management in pediatric acute pancreatitis: opioid versus non-opioid. J Pediatr Gastroenterol Nutr 66(2):295–298PubMedCrossRef

Habashy C, Springer E, Hall EA et al (2018) Methadone for pain management in children with cancer. Pediatr Drugs 20(5):409–416CrossRef

Hallett BR, Chalkiadis GA (2012) Suspected opioid-induced hyperalgesia in an infant. Br J Anaesth 108(1):116–118PubMedCrossRef

Hanks GW, Conno F, Cherny N et al (2001) Expert working group of the research network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587–593PubMedPubMedCentralCrossRef

Hannam JA, Anderson BJ, Potts A (2018) Acetaminophen, ibuprofen, and tramadol analgesic interactions after adenotonsillectomy. Paediatr Anaesth 28(10):841–851PubMedCrossRef

Hansen MS, Mathiesen O, Trautner S et al (2012) Intranasal fentanyl in the treatment of acute pain: a systematic review. Acta Anaesthesiol Scand 56(4):407–419PubMedCrossRef

Hartenstein-Pinter A, Hübner-Möhler B, Zernikow B et al (2020) Verbandsmaterial bei Kindern mit Epidermolysis bullosa. Eine qualitative Studie zu den Erfahrungen von Eltern und betroffenen Kindern. Schmerz 34:156–165PubMedCrossRef

Haupt TS, Smyth M, Gregoire M-C (2019) A scoping review of transdermal buprenorphine use for non-surgical pain in the pediatric population. Cureus 11(10):e5954PubMedPubMedCentral

He M, Zhang B, Shen N et al (2018) A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur J Pediatr 177(1):7–17PubMedCrossRef

Heger S, Maier C, Otter K et al (1999) Lesson of the week: morphine induced allodynia in a child with brain tumour. What is allodynia? Br Med J 319(7210):627–629CrossRef

Hicks CL, von Baeyer CL, Spafford PA et al (2001) The faces pain scale – revised: toward a common metric in pediatric pain measurement. Pain 93:173–183PubMedCrossRef

Hockenberry MJ, McCarthy K, Taylor O et al (2011) Managing painful procedures in children with cancer. J Pediatr Hematol Oncol 33(2):119–127PubMedCrossRef

Holdgate A, Cao A, Lo KM (2010) The implementation of intranasal fentanyl for children in a mixed adult and pediatric emergency department reduces time to analgesic administration. Acad Emerg Med 17:214–217PubMedCrossRef

Holzman RS, Cullen DJ, Eichhorn JH et al (1994) Guidelines for sedation by nonanaesthesiologists during diagnostic and therapeutic procedures. J Clin Anesth 6:265–276PubMedCrossRef

Horst J, Frei-Jones M, Deych E et al (2016) Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease. Pediatr Blood Cancer 63(12):2123–2130PubMedPubMedCentralCrossRef

Hoy SM (2012) Tapentadol extended release: in adults with chronic pain. Drugs 72(3):375–393PubMedCrossRef

Hunt A, Goldman A, Seers K et al (2004) Clinical validation of the paediatric pain profile. Dev Med Child Neurol 46(1):9–18PubMedCrossRef

Hurd YL, Manzoni OJ, Pletnikov MV et al (2019) Cannabis and the developing brain: insights into its long-lasting effects. J Neurosci 39(42):8250–8258PubMedPubMedCentralCrossRef

Hurwitz ES (1989) Reyeïs syndrome. Epidemiol Rev 11:249–253PubMedCrossRef

Jain S (2018) Sedation: a primer for pediatricians. Pediatr Ann 47(6):e254–e2e8PubMedCrossRef

James PJ, Howard RF, Williams DG (2010) The addition of ketamine to a morphine nurse or patient controlled analgesia infusion (PCA/NCA) increases analgesic efficacy in children with mucositis pain. Paediatr Anaesth 20(9):805–811PubMedCrossRef

Jassal SS, Brook L, Aindow A (2020) The Association of Paediatric Palliative Medicine – Master Formulary (APPM, 5th edition). https://www.appm.org.uk/guidelines-resources/appm-master-formulary/ letzter Zugriff: 13.03.2021

Jokela R, Ahonen J, Seitsonen E et al (2010) The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. Clin Pharmacol Ther 87(6):672–678PubMedCrossRef

Jóźwiak-Bebenista M, Nowak JZ (2014) Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm 71(1):11–23PubMed

Khurmi N, Patel P, Kraus M et al (2017) Pharmacologic considerations for pediatric sedation and anesthesia outside the operating room: a review for anesthesia and non-anesthesia providers. Pediatr Drugs 19(5):435–446CrossRef

Kinnunen M, Piirainen P, Kokki H et al (2019) Updated clinical pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacokinet 58(6):705–725PubMedCrossRef

Kotecha RS, Powers N, Lee SJ et al (2010) Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL). Pediatr Blood Cancer 54(7):934–940PubMedCrossRef

Kovac AL (2007) Management of postoperative nausea and vomiting in children. Pediatr Drugs 9(1):47–69CrossRef

Krause I, Cleper R, Eisenstein B et al (2005) Acute renal failure, associated with non-steroidal anti-inflammatory drugs in healthy children. Pediatr Nephrol 20(9):1295–1298PubMedCrossRef

Kübler-Ross E (2000) Kinder und Tod. Knaur, Stuttgart

Kuehn BM (2013) FDA: no codeine after tonsillectomy for children. J Am Med Assoc 309(11):1100CrossRef

Landesinitiative NRW zur Erforschung der Palliativversorgung von Kindern und Jugendlichen (2009) Ambulante Palliativversorgung von Kindern und Jugendlichen. Abschlussbericht der Begleitforschung zur nordrhein-westfälischen Landesinitiative. https://broschuerennordrheinwestfalendirektde/broschuerenservice/mhkbg/ambulante-palliativversorgung-von-kindern-und-jugendlichen/160

Lange N (2019) Editorial: brain mediators of the cannabis-prodromal psychosis connection. J Am Acad Child Adolesc Psychiatry 59(5):592–594PubMedCrossRef

Laubisch JE, Baker JN (2013) Methylnaltrexone use in a seventeen-month-old female with progressive cancer and rectal prolapse. J Palliat Med 16(11):1486–1488PubMedPubMedCentralCrossRef

Lee JM, Mooney J (2012) Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient. Clin J Pain 28(4):338–341PubMedCrossRef

Leroy S, Mosca A, Landre-Peigne C et al (2007) Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr 14(5):477–484PubMedCrossRef

Li X, Zuo Y, Dai Y (2012) Children’s seizures caused by continuous intravenous infusion of tramadol analgesia: two rare case reports. Paediatr Anaesth 22(3):308–309PubMedCrossRef

Liow NY-K, Gimeno H, Lumsden DE et al (2016) Gabapentin can significantly improve dystonia severity and quality of life in children. Eur J Paediatr Neurol 20(1):100–107PubMedCrossRef

López J, Fernández SN, Santiago MJ et al (2016) Methylnaltrexone for the treatment of constipation in critically ill children. J Clin Gastroenterol 50(4):351–352PubMedCrossRef

Mackey AC, Green L, Greene P et al (2010) Methylnaltrexone and gastrointestinal perforation. J Pain Symptom Manag 40(1):e1–e3CrossRef

Madden K, Bruera E (2017) Very-low-dose methadone to treat refractory neuropathic pain in children with cancer. J Palliat Med 20(11):1280–1283PubMedCrossRef

Madden K, Park M, Liu D et al (2017) The frequency of QTc prolongation among pediatric and young adult patients receiving methadone for cancer pain. Pediatr Blood Cancer 64(11):e26614CrossRef

Madden K, Mills S, Dibaj S et al (2018) Methadone as the initial long-acting opioid in children with advanced cancer. J Palliat Med 21(9):1317–1321PubMedCrossRef

Malviya S, Voepel-Lewis T, Burke C et al (2006) The revised FLACC observational pain tool: improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth 16(3):258–265PubMedCrossRef

Maritaz C, Lemare F, Laplanche A et al (2018) High-dose thiotepa-related neurotoxicity and the role of tramadol in children. BMC Cancer 18(1):177PubMedPubMedCentralCrossRef

Maunuksela EL, Korpela R, Olkkola KT (1988) Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain in children. Br J Anaesth 60:48–55PubMedCrossRef

Maxwell LG, Kaufmann SC, Bitzer S et al (2005) The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg 100(4):953–958PubMedCrossRef

McNicol ED, Ferguson MC, Haroutounian S et al (2016) Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain. Cochrane Database Syst Rev (5):CD007126

Mercadante S (2012) Pharmacotherapy for breakthrough cancer pain. Drugs 72(2):181–190PubMedCrossRef

Mercadante S, Ferrera P, Villari P et al (2005) Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 23(22):5229–5234PubMedCrossRef

Mercadante S, Ferrera P, Adile C et al (2011) Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose. J Pain Symptom Manag 42(464):469

Merker M, Dinges G, Koch T et al (2012) Unerwünschte Nebenwirkungen von Tapentadol im Vergleich zu Oxycodon. Schmerz 26(1):16–26PubMedCrossRef

Meyer S, Kleinschmidt S (2005) Diagnostische und therapeutische Prozeduren. Sedierung und Analgesie im Kindesalter. Monatsschr Kinderheilk 153:291–303CrossRef

Michel E, Zernikow B (2006) Buprenorphineinsatz bei Kindern. Eine klinisch-pharmakologische Übersicht. Monatsschr Kinderheilk 154:799–807CrossRef

Michel E, Anderson BJ, Zernikow B (2011) Buprenorphine TTS for children – a review of the drug’s clinical pharmacology. Paediatr Anaesth 21(3):280–290PubMedCrossRef

Miller JL, Hagemann TM (2011) Use of pure opioid antagonists for management of opioid-induced pruritus. Am J Health Syst Pharm 68(15):1419–1425PubMedCrossRef

Monitto CL, Kost-Byerly S, White E et al (2011) The optimal dose of prophylactic intravenous naloxone in ameliorating opioid-induced side effects in children receiving intravenous patient-controlled analgesia morphine for moderate to severe pain: a dose finding study. Anesth Analg 113(4):834–842PubMedPubMedCentralCrossRef

Moreno-Izco F, Ruibal M (2006) Myoclonic seizures induced by tramadol in patients with juvenile myoclonic epilepsy. Rev Neurol 43(4):255PubMed

Mott C, Sarpal A, Moss K et al (2018) Methadone for analgesia in children with life-limiting illness: experience from a tertiary children’s health service. Child Aust 5(7):86CrossRef

Muller C, Kremer W, Harlfinger S et al (2006) Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units. Eur J Pediatr 165:229–239PubMedCrossRef

Murat I, Baujard C, Foussat C et al (2005) Tolerance and analgesic efficacy of a new i.v. paracetamol solution in children after inguinal hernia repair. Paediatr Anaesth 15:663–670PubMedCrossRef

Muse D, Tarau E, Lefeber C et al (2019) Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients. J Pain Res 12:1777–1790PubMedPubMedCentralCrossRef

Nijland L, Schmidt P, Frosch M et al (2019) Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review. Support Care Cancer 27(1):33–42PubMedCrossRef

No author listed (2010) Fentanyl sublingual tablets. Breakthrough pain: new formulation, no therapeutic advantage. Prescrire Int 19(105):16

Nolte-Buchholtz S, Zernikow B, Wager J (2018) Pediatric Patients Receiving Specialized Palliative Home Care According to German Law: A Prospective Multicenter Cohort Study. Children (Basel, Switzerland) 5(6):E66

Nunez-Olarte JM, Varez-Jimnez P (2011) Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain. J Pain Symptom Manag 42(6):e6–e8CrossRef

Passik SD, Messina J, Golsorkhi A et al (2010) Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manag 41(116):125

Pawliuk C, Widger K, Dewan T et al (2020) Scoping review of symptoms in children with rare, progressive, life-threatening disorders. BMJ Support Palliat Care 10(1):91–104

Perito ER, Palermo TM, Pohl JF et al (2020) Factors associated with frequent opioid use in children with acute recurrent and chronic pancreatitis. J Pediatr Gastroenterol Nutr 70(1):106–114PubMedPubMedCentralCrossRef

Philippi-Höhne C, Becke K, Wulff B et al (2010) Entschließung zur Analgosedierung für diagnostische und therapeutische Verfahren im Kindesalter. Anästh Intensivmed 51:603–614

Pickering G, Loriot MA, Libert F et al (2006) Analgesic effect of acetaminophen in humans. First evidence of a central serotonergic effect. Clin Pharmacol Ther 79:371–379PubMedCrossRef

Pierce DM, Shipstone E (2012) Pharmacology update: tapentadol for neuropathic pain. Am J Hosp Palliat Med 29(8):663–666CrossRef

Pokela ML, Anttilla E, Seppäla T et al (2005) Marked variation in oxycodone pharmacokinetics in infants. Paediatr Anaesth 15:560–565PubMedCrossRef

Pollock AB, Tegeler ML, Morgan V et al (2011) Morphine to methadone conversion: an interpretation of published data. Am J Hosp Palliat Med 28(2):135–140CrossRef

Pritchard M, Burghen E, Srivastava DK et al (2008) Cancer-Related Symptoms Most Concerning to Parents During the Last Week and Last Day of Their Child‘s Life. Pediatrics 121(5):e1301–e9

Prows CA, Zhang X, Huth MM et al (2014) Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study. Laryngoscope 124(5):1242–1250PubMedCrossRef

Racoosin JA, Roberson DW, Pacanowski MA et al (2013) New evidence about an old drug – risk with codeine after adenotonsillectomy. N Engl J Med 368(23):2155–2157PubMedCrossRef

Rasmussen VF, Lundberg V, Jespersen TW et al (2015) Extreme doses of intravenous methadone for severe pain in two children with cancer. Pediatr Blood Cancer 62(6):1087–1090PubMedCrossRef

Reinhold P, Köster-Oehlmann P (2015) Schmerzhafte interventionelle Eingriffe. In: Zernikow B (Hrsg) Schmerztherapie bei Kindern, Jugendlichen und jungen Erwachsenen. Springer Medizin, Heidelberg, S 369–387CrossRef

Remy C (2019) Ungewöhnliche Patienten erfordern ungewöhnliche Arzneimittellösungen (Vortrag). In: Klinik und Poliklinik für Palliativmedizin KdUM (Hrsg) Dattelner Kinderschmerztage 2019, Recklinghausen. https://kinderpalliativzentrum.de/wp-content/uploads/2019/05/DKST2019_Remi_-Ungewöhnliche-Patienen-erfordern-ungewöhnliche-Arzneimittellösungen.pdf

Riad W, Moussa A (2007) Pre-operative analgesia with rectal diclofenac and/or paracetamol in children undergoing inguinal hernia repair. Anaesthesia 62(12):1241–1245PubMedCrossRef

Ripamonti C, Groff L, Brunelli C et al (1998) Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 16:3216–3221PubMedCrossRef

Robb PJ (2013) More codeine fatalities after tonsillectomy in North American children. Time to revise prescribing practice! Clin Otolaryngol 38(5):365–367PubMedCrossRef

Robinson WM, Ravilly S, Berde C et al (1997) End-of-life care in cystic fibrosis. Pediatrics 100:205–209PubMedCrossRef

Rodieux F, Vutskits L, Posfay-Barbe KM et al (2018) When the safe alternative is not that safe: tramadol prescribing in children. Front Pharmacol 9:148PubMedPubMedCentralCrossRef

Rodrigues A, Wong C, Mattiussi A et al (2013) Methylnaltrexone for opioid-induced constipation in pediatric oncology patients. Pediatr Blood Cancer 60(10):1667–1670PubMedCrossRef

Romsing J, Moiniche S, Dahl JB (2002) Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia. Br J Anaesth 88(2):215–226PubMedCrossRef

Rusy LM, Hainsworth KR, Nelson TJ et al (2010) Gabapentin use in pediatric spinal fusion patients: a randomized, double-blind, controlled trial. Anesth Analg 110(5):1393PubMedCrossRef

Sabatowski R, Kasper SM, Radbruch L (2002) Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine. J Pain Symptom Manag 23(1):3–5CrossRef

Sallee FR, Nesbitt L, Jackson C et al (1997) Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorder. Am J Psychiatry 154:1057–1062PubMedCrossRef

Saunders C (1978) The philosophy of terminal care. In: Saunders C (Hrsg) The management of terminal disease. Arnold, London

Saunders C (2006) The Management of Terminal Illness, 1967. In: Saunders C (ed) Selected Writings 1958-2004. Oxford University Press, Oxford, pp 91–114

Savino F, Lupica MM, Tarasco V et al (2011) Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant. Pediatrics 127(2):e494–e4e7PubMedCrossRef

Schiessl C, Gravou C, Zernikow B et al (2008a) Use of patient-controlled analgesia for pain control in dying children. Support Care Cancer 16(5):531–536PubMedCrossRef

Schiessl C, Sittl R, Griessinger N et al (2008b) Intravenous morphine consumption in outpatients with cancer during their last week of life-an analysis based on patient-controlled analgesia data. Support Care Cancer 16(8):917–923PubMedCrossRef

Setlur A, Friedland H (2018) Treatment of pain with intranasal fentanyl in pediatric patients in an acute care setting: a systematic review. Pain Manag 8(5):341–352PubMedCrossRef

Shannon M, Berde CB (1989) Pharmacologic management of pain in children and adolescents. Pediatr Clin N Am 36:855–871CrossRef

Shillingburg A, Kanate AS, Hamadani M et al (2017) Treatment of severe mucositis pain with oral ketamine mouthwash. Support Care Cancer 25(7):2215–2219PubMedPubMedCentralCrossRef

Siden H (2007) The boy who refused an IV: a case report of subcutaneous clodronate for bone pain in a child with Ewing Sarcoma. J Med Case Rep 1(1):1–4CrossRef

Siden H, Nalewajek V (2003) High dose opioids in pediatric palliative care. J Pain Symptom Manag 25:397–399CrossRef

Simm PJ, Biggin A, Zacharin MR et al (2018) Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 54(3):223–233PubMedCrossRef

Sirkiä K, Hovi L, Pouttu J et al (1998) Pain medication during terminal care of children with cancer. J Pain Symptom Manag 15:220–226CrossRef

Slatkin N, Thomas J, Lipman AG et al (2009) Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 7(1):39–46PubMed

Slatkin NE, Lynn R, Su C et al (2011) Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials. J Pain Symptom Manag 42(5):754–760CrossRef

Smith ER (2000) Research design. In: Reis HT, Judd CM (Hrsg) Handbook of research methods in social and personality psychology. Cambridge University Press, Cambridge, S 17–39

Squires RH Jr, Shneider BL, Bucuvalas J et al (2006) Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 148(5):652–658PubMedPubMedCentralCrossRef

Staff NP, Cavaletti G, Islam B et al (2019) Platinum-induced peripheral neurotoxicity: from pathogenesis to treatment. J Peripher Nerv Syst 24:S26–S39PubMedPubMedCentralCrossRef

Stamer U, Stüber F (2004) Pharmakogenetik und pädiatrische Schmerztherapie. Kinder Jugendmed 4:161–167CrossRef

Staritz M (1988) Pharmacology of the sphincter of Oddi. Endoscopy 20(Suppl 1):171–174PubMedCrossRef

Swarm RA, Paice JA, Anghelescu DL et al (2019) Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 17(8):977–1007CrossRef

Tatla SK, Holsti L, Andrews GS et al (2017) Charting the territory: Describing the functional abilities of children with progressive neurological conditions. Res Dev Disabil 71:191–9

Taylor M, Jakacki R, May C et al (2015) Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics. Am J Hosp Palliat Med 32(8):841–848CrossRef

Thigpen JC, Odle BL, Harirforoosh S (2019) Opioids: a review of pharmacokinetics and pharmacodynamics in neonates, infants, and children. Eur J Drug Metab Pharmacokinet 44:591–609PubMedCrossRef

Thomas J, Karver S, Cooney GA et al (2008) Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358(22):2332–2343PubMedCrossRef

Thwaites D, McCann S, Broderick P (2004) Hydromorphone neuroexcitation. J Palliat Med 7:545–550PubMedCrossRef

Tietze AL, Zernikow B, Hirschfeld G et al (2012) Sleep and Quality of life in parents of children with severe psychomotor impairments. Sleep Med 16(2):117–27Tietze AL, Zernikow B, Michel E et al (2014a) Sleep disturbances in children, adolescents, and young adults with severe psychomotor impairment: impact on parental quality of life and sleep. Dev Med Child Neurol 56(12):1187–93Tietze AL, Zernikow B, Otto M et al (2014b) The development and psychometric assessment of a questionnaire to assess sleep and daily troubles in parents of children and young adults with severe psychomotor impairment. Sleep Med 15(2):219–27

Tomasello C, Pinto RM, Mennini C et al (2018) Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents: a preliminary study. Pediatr Blood Cancer 65(7):e27064PubMedCrossRef

Trang T, Al-Hasani R, Salvemini D et al (2015) Pain and poppies: the good, the bad, and the ugly of opioid analgesics. J Neurosci 35(41):13879–13888PubMedPubMedCentralCrossRef

Tsui BC, Davies D, Desai S et al (2004) Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. J Pediatr Hematol Oncol 26:678–680PubMedCrossRef

Viitanen H, Tuominen N, Vaaraniemi H et al (2003) Analgesic efficacy of rectal acetaminophen and ibuprofen alone or in combination for paediatric day-case adenoidectomy. Br J Anaesth 91(3):363–367PubMedCrossRef

Vondracek P, Oslejskova H, Kepak T et al (2009) Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol 13(4):1–332CrossRef

van Voorthuizen T, Helmers JH, Tjoeng MM et al (2000) Meperidine (pethidine) outdated as analgesic in acute pancreatitis. Ned Tijdschr Geneeskd 144(14):656–658PubMed

Wager J, Hechler T, Hünseler C et al (2015) Messen und Erfassen von Schmerz. In: Zernikow B (Hrsg) Schmerztherapie bei Kindern, Jugendlichen und jungen Erwachsenen. Springer, Berlin/Heidelberg, S 75–104CrossRef

Wagner S, Poirot I, Vuillerot C et al (2011) Tolerance and effectiveness on pain control of Pamidronate – intravenous infusions in children with neuromuscular disorders. Ann Phys Rehabil Med 54(6):348–358PubMedCrossRef

Watson E, Khandelwal A, Freijer J et al (2019) Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population. J Pain Res 12:2835–2850PubMedPubMedCentralCrossRef

Watterson G, Howard R, Goldmann A (2004) Peripheral opioids in inflammatory pain. Arch Dis Child 89:679–681PubMedPubMedCentralCrossRef

Weisman SJ, Bernstein B, Schechter NL (1998) Consequences of inadequate analgesia during painful procedures in children. Arch Pediatr Adolesc Med 152:147–149PubMedCrossRef

West N, Ansermino JM, Carr RR et al (2015) A naloxone admixture to prevent opioid-induced pruritus in children: a randomized controlled trial. Can J Anaesth 62(8):891–900PubMedCrossRef

White MC, Hommers C, Parry S et al (2010) Pain management in 100 episodes of severe mucositis in children. Paediatr Anaesth 20(9):805–811

Whiting PF, Wolff RF, Deshpande S et al (2015) Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313(24):2456–2473PubMedCrossRef

Wilens TE, Biederman J, Baldessarini RJ et al (1996) Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35:1491–1501PubMedCrossRef

Wong SS, Wilens TE (2017) Medical cannabinoids in children and adolescents: a systematic review. Pediatrics 140(5):e20171818PubMedCrossRef

Wright AW, Nocente ML, Smith MT (1998) Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation. Life Sci 63:401–411PubMedCrossRef

Wright AW, Mather LE, Smith MT (2001) Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sci 69(4):409–420PubMedCrossRef

Yarkan Uysal H, Bilimgut B, Dikmen B et al (2011) Epileptic seizure following IV tramadol in a patient with mental retardation and cerebellar ataxia. Pain Med 12(5):833–836PubMedCrossRef

Yaster M, Krane EJ, Kaplan RF et al (1997) Pediatric pain and sedation handbook. Mosby, St Louis

Zanette G, Manani G, Giusti F et al (1996) Respiratory depression following administration of low dose buprenorphine as postoperative analgesic after fentanyl balanced anaesthesia. Paediatr Anaesth 6:419–422PubMedCrossRef

Zempsky WT, Loiselle KA, Corsi JM et al (2010) Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series. Clin J Pain 26(2):163–167PubMedCrossRef

Zernikow B (Hrsg) (2021) Pädiatrische Palliativversorgung – Grundlagen, 3. Aufl. Springer, Berlin/Heidelberg

Zernikow B, Dietz B (2003) Schmerzerkennung, -messung und -therapie bei Kindern mit kognitiver und körperlicher Behinderung. Neuropädiatr Klin Prax 2(1):12–17

Zernikow B, Hasan C (2015) Schmerztherapie bei lebensbedrohlichen und lebenslimitierenden Erkrankungen. In: Zernikow B (Hrsg) Schmerztherapie bei Kindern, Jugendlichen und jungen Erwachsenen. Springer, Berlin, S 439–479CrossRef

Zernikow B, Lindena G (2001) Long-acting morphine for pain control in paediatric oncology. Med Pediatr Oncol 36(4):451–458PubMedCrossRef

Zernikow B, Bauer AB, Andler W (2002) Schmerzkontrolle in der pädiatrischen Onkologie in Deutschland – Eine Bestandsaufnahme. Schmerz 16(2):140–149PubMedCrossRef

Zernikow B, Meyerhoff U, Michel E et al (2005a) Pain in pediatric oncology – children’s and parents’ perspectives. Eur J Pain 9(4):395–406PubMedCrossRef

Zernikow B, Schiessl C, Wamsler C et al (2005b) Opioidtherapie chronischer Schmerzen bei Kindern -- Fallbesprechungen. Schmerz 19(5):418–425PubMedCrossRef

Zernikow B, Smale H, Michel E et al (2006) Paediatric cancer pain management using the WHO analgesic ladder – results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain 10(7):587–595PubMedCrossRef

Zernikow B, Michel E, Anderson BJ (2007) Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. J Pain 8(3):187–207PubMedCrossRef

Zernikow B, Michel E, Craig F et al (2009) Pediatric palliative care: use of opioids for the management of pain. Pediatr Drugs 11(2):129–151CrossRef

Zernikow B, Hasan C, Baumann-Köhler M et al (2013) Praktische Schmerztherapie. In: Zernikow B (Hrsg) Palliativversorgung von Kindern Jugendlichen und jungen Erwachsenen. Springer, Heidelberg, S 107–144CrossRef

Zernikow B, Szybalski K, Hübner-Mohler B et al (2019) Specialized pediatric palliative care services for children dying from cancer: A repeated cohort study on the developments of symptom management and quality of care over a 10-year period. Palliat Med 33(3):381–91

Titel: Praktische
verfasst von: Boris Zernikow
Michael Printz
Verlag: Springer Berlin Heidelberg
Buch: Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle
Print ISBN: 978-3-662-63147-8

Electronic ISBN: 978-3-662-63148-5

Copyright-Jahr: 2022
DOI: https://doi.org/10.1007/978-3-662-63148-5_2

Neu im Fachgebiet Pädiatrie

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen